Drugs / PRP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04392999 | Feb 2021 → Mar 2023 | — | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | “Group A will receive an intra-articular (IA) injection of autologous PRP (0.5 mL per level)” NCT04392999 ↗ |
| Route | Other | “Group A will receive an intra-articular (IA) injection of autologous PRP (0.5 mL per level)” NCT04392999 ↗ |